Antiangiogenic Tyrosine Kinase Inhibitors: Occurrence and Risk Factors of Hemoptysis in Refractory Thyroid Cancer. Lamartina, L.; Ippolito, S.; Danis, M.; Bidault, F.; Borget, I.; Berdelou, A.; Al Ghuzlan, A.; Hartl, D.; Blanchard, P.; Terroir, M.; Deandreis, D.; Schlumberger, M.; Baudin, E.; Leboulleux, S.. J Clin Endocrinol Metab. 2016; 2733-41: p.2733-41. doi:10.1210/jc.2015-4391 10.1210/jc.2015-4391. Epub 2016 Apr 15.Article
Oncostat